Submitted by Anonymous (not verified) on 8 October 2026 - 14:22
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 19, Status: Authorised